Global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one driver in the market is rise in STDs. The rise in STDs has become a global public health challenge. STDs include more than 25-30 infectious diseases that are spread through sexual activity. A person needs to visit a health clinic or hospital for STD testing and treatment if exposed to a sexually transmitted pathogen. Common STDs include chlamydia, syphilis, gonorrhea, herpes, HPV, and HIV infections.
One trend in the market is high demand for POC testing. The diagnostic sector is undergoing revolutionary changes, with device miniaturization, growth in testing menus, and the introduction of multi-parameter testing devices. Another significant development in this sector is the emergence of POC testing.
Further, the report states that one challenge in the market is lack of trained professionals. STD testing requires extensive optimization before results can be interpreted correctly. Therefore, clinical laboratories and diagnostic centers require trained specialists. However, there is a global shortage of these specialists in diagnostic centers and hospitals. For instance, most rural hospitals in the US face issues such as low patient volume and are unable to justify the expenses associated with employing specialists who charge high.